A positive mindset and resilience are crucial in overcoming the challenges of a cancer diagnosis and can be cultivated ...

CAMBRIDGE, Mass., Jan. 5, 2026 /PRNewswire/ --MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive ...

SALT LAKE CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (along with its subsidiaries, “Clene” or the “Company”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a late clinical-stage ...

Chief Research Scientist, CSIRO Environment; Executive Director, Global Carbon Project, CSIRO Pep Canadell receives funding from the Australian National Environmental Science Program - Climate Systems ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Positive full results from the Bax24 Phase III trial showed baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in ...

*The main analyses of ambulatory BP endpoints include patients with valid ambulatory blood pressure monitoring at both baseline and Week 12, without imputation of missing data. The Phase III Bax24 ...

Princess U. Ogbogu, Division Chief of Pediatric Allergy, Immunology, and Rheumatology at University Hospitals Rainbow Babies and Children’s Hospital and Case Western Reserve University, Cleveland, OH, ...

Positive full results from the NATRON Phase III trial showed AstraZeneca’s FASENRA(benralizumab) demonstrated a statistically significant delay in the time to first worsening or flare in ...

and quality of life, shown through achievement of sPGA0/1 and DLQI0/1 in the HRO350 group after 1 year. The results show that patient screening based on baseline SII in mild-to -moderate psoriasis may ...

Abstract: Brightness temperature difference (TBD) derived from microwave radiometers (MRMs) onboard the Chang’e (CE)-1/2 satellites has been widely used to characterize basaltic flows on the lunar ...

The inclusion of BATURA study results in the US prescribing information builds upon the previous MANDALA Phase III trial in adult patients with moderate to severe asthma. 3 The MANDALA and BATURA ...